BioSpace News Archive

OCSiAl, the world’s largest manufacturer of graphene nanotubes, recently was added to the CB Insights Global Unicorn Club, a list of startup companies valued at $1 billion or more.

Elligo Health Research, a healthcare-enabling research organization, announces its partnership with Austin Cancer Center, the largest independent oncology group in central Texas.

Gilead will have exclusive rights to Lyndra’s platform for HIV therapies

New analyses from Phase III HAVEN studies support Hemlibra’s sustained efficacy, safety and quality of life benefit in people with hemophilia A, with and without factor VIII inhibitors

Fully human, potentially first-in-class, monoclonal antibody designed to target a fundamental immunosuppressive mechanism in hard-to-treat cancers

Providing researchers with an automated solution for two-step nucleic acid sample preparation

Exact Sciences Corp. announced that the company will host webcasts and conference calls of its annual stockholders meeting and its second-quarter 2019 financial results.

Blue Water Vaccines, a company developing a universal flu vaccine based on technology developed at the University of Oxford, has closed a $7 million seed capital round led by CincyTech.

Argon Medical Devices, Inc., a leading global manufacturer of specialty medical devices used in interventional procedures, announced that it has entered into a definitive license agreement with Hatch Medical, L.L.C. for exclusive global rights to market and distribute the Scorpion™ TIPS Access Systems.

IDEAYA Biosciences, Inc., an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics to treat cancer, announced the promotions of Paul A. Stone, J.D., as Chief Financial Officer, Andres Briseno, C.P.A., as Vice President, Finance, and Mick O’Quigley, M.B.A., as Vice President, Development Operations.